STRUCTURAL REQUIREMENTS FOR THE BINDING OF TRNA(3)(LYS) TO REVERSE-TRANSCRIPTASE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

被引:33
作者
ESSINK, BBO [1 ]
DAS, AT [1 ]
BERKHOUT, B [1 ]
机构
[1] UNIV AMSTERDAM, ACAD MED CTR, DEPT VIROL, 1105 AZ AMSTERDAM, NETHERLANDS
关键词
D O I
10.1074/jbc.270.40.23867
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Reverse transcription of the human immunodeficiency virus type 1 (HIV-1) RNA genome is primed by the cellular tRNA(3)(Lys) molecule. Packaging of this tRNA primer during virion assembly is thought to be mediated by specific interactions with the reverse transcriptase (RT) protein. Portions of the tRNA molecule that are required for interaction with the RT protein remain poorly defined. We have used an RNA gel mobility shift assay to measure the in vitro binding of purified RT to mutant forms of tRNA(3)(Lys). The anticodon loop could be mutated without eliminating RT recognition. However, mutations in the T Psi C stem were found to partially interfere with RT binding, and D arm mutants were completely inactive in RT binding. Interestingly, binding of the RT protein to tRNA(3)(Lys) facilitates the subsequent annealing of template strand to the 3'-terminus of the tRNA molecule. Consistent with this finding, we demonstrate that mutant HIV-1 virions lacking the RT protein do contain a viral RNA genome without an associated tRNA(3)(Lys) primer. We also found that a preformed primer tRNA-template complex is efficiently recognized by RT protein in vitro. Extension of the template molecule over the T Psi C loop did result in complete inhibition of RT binding, suggesting the presence of additional recognition elements in the T Psi C loop. These results, combined with a comparative sequence analysis of tRNA species present in HIV-1 virions and RNA motifs selected in vitro for high affinity RT binding, suggest that RT recognizes the central domain of the tRNA tertiary structure, which is formed by interaction of the D and T Psi C loops.
引用
收藏
页码:23867 / 23874
页数:8
相关论文
共 53 条
[1]   INTERACTION BETWEEN RETROVIRAL-U5 RNA AND THE T-PSI-C LOOP OF THE TRANSFER RNATRP PRIMER IS REQUIRED FOR EFFICIENT INITIATION OF REVERSE TRANSCRIPTION [J].
AIYAR, A ;
COBRINIK, D ;
GE, Z ;
KUNG, HJ ;
LEIS, J .
JOURNAL OF VIROLOGY, 1992, 66 (04) :2464-2472
[2]   AFFINITY LABELING AND FUNCTIONAL-ANALYSIS OF THE PRIMER BINDING DOMAIN OF HIV-1 REVERSE-TRANSCRIPTASE [J].
ANDREOLA, ML ;
TARRAGOLITVAK, L ;
LEVINA, AS ;
KOLOCHEVA, TI ;
ELDIRANIDIAB, R ;
JAMKOVOY, VI ;
KHALIMSKAYA, NL ;
BARR, PJ ;
LITVAK, S ;
NEVINSKY, GA .
BIOCHEMISTRY, 1993, 32 (14) :3629-3637
[3]   STRUCTURE OF HIV-1 REVERSE-TRANSCRIPTASE DNA COMPLEX AT 7-A RESOLUTION SHOWING ACTIVE-SITE LOCATIONS [J].
ARNOLD, E ;
JACOBOMOLINA, A ;
NANNI, RG ;
WILLIAMS, RL ;
LU, XD ;
DING, JP ;
CLARK, AD ;
ZHANG, AQ ;
FERRIS, AL ;
CLARK, P ;
HIZI, A ;
HUGHES, SH .
NATURE, 1992, 357 (6373) :85-89
[4]   INTERACTION OF HIV-1 REVERSE-TRANSCRIPTASE WITH A SYNTHETIC FORM OF ITS REPLICATION PRIMER, TRANSFER RNALYS,3 [J].
BARAT, C ;
LEGRICE, SFJ ;
DARLIX, JL .
NUCLEIC ACIDS RESEARCH, 1991, 19 (04) :751-757
[5]   HIV-1 REVERSE-TRANSCRIPTASE SPECIFICALLY INTERACTS WITH THE ANTICODON DOMAIN OF ITS COGNATE PRIMER TRANSFER-RNA [J].
BARAT, C ;
LULLIEN, V ;
SCHATZ, O ;
KEITH, G ;
NUGEYRE, MT ;
GRUNINGERLEITCH, F ;
BARRESINOUSSI, F ;
LEGRICE, SFJ ;
DARLIX, JL .
EMBO JOURNAL, 1989, 8 (11) :3279-3285
[6]   SECONDARY STRUCTURE OF THE HIV-2 LEADER RNA COMPRISING THE TRANSFER RNA-PRIMER BINDING-SITE [J].
BERKHOUT, B ;
SCHONEVELD, I .
NUCLEIC ACIDS RESEARCH, 1993, 21 (05) :1171-1178
[7]   INVITRO DIMERIZATION OF HIV-2 LEADER RNA IN THE ABSENCE OF PUGGAPUA MOTIFS [J].
BERKHOUT, B ;
ESSINK, BBO ;
SCHONEVELD, I .
FASEB JOURNAL, 1993, 7 (01) :181-187
[8]   INHIBITION OF THE P66/P51 FORM OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE BY TRANSFER RNALYS [J].
BORDIER, B ;
TARRAGOLITVAK, L ;
SALLAFRANQUEANDREOLA, ML ;
ROBERT, D ;
THARAUD, D ;
FOURNIER, M ;
BARR, PJ ;
LITVAK, S ;
SARIHCOTTIN, L .
NUCLEIC ACIDS RESEARCH, 1990, 18 (03) :429-436
[9]   OVERLAPPING RETROVIRUS U5 SEQUENCE ELEMENTS ARE REQUIRED FOR EFFICIENT INTEGRATION AND INITIATION OF REVERSE TRANSCRIPTION [J].
COBRINIK, D ;
AIYAR, A ;
GE, Z ;
KATZMAN, M ;
HUANG, H ;
LEIS, J .
JOURNAL OF VIROLOGY, 1991, 65 (07) :3864-3872
[10]   HUMAN-IMMUNODEFICIENCY-VIRUS USES TRNA(LYS,3) AS PRIMER FOR REVERSE TRANSCRIPTION IN HELA-CD4(+) CELLS [J].
DAS, AT ;
KOKEN, SEC ;
ESSINK, BBO ;
VANWAMEL, JLB ;
BERKHOUT, B .
FEBS LETTERS, 1994, 341 (01) :49-53